Features of high-risk multiple myeloma and how to treat it

Keith Stewart, MB, ChB from the Mayo Clinic, Scottsdale, AZ gives an overview of his talk on the management and treatment of high-risk multiple myeloma (MM) patients. According to Prof Stewart, high-risk features can be found in approximately 15-25% of patients and include the 17p deletion, serum translocations, and the alleviation of LDH in the peripheral blood. Prof Stewart further discusses how to treat high-risk patients and this includes triplet therapy, the importance of achieving a molecular complete remission (CR), the role of a second transplant and the promise of immunotherapy.
Recorded at the American Society of Oncology (ASCO) 2016 Annual Meeting held in Chicago, IL.

Share this video